Your browser doesn't support javascript.
loading
A Two-color Single-molecule Sequencing Platform and Its Clinical Applications.
Chen, Fang; Liu, Bin; Chen, Meirong; Jiang, Zefei; Zhou, Zhiliang; Wu, Ping; Zhang, Meng; Jin, Huan; Li, Linsen; Lu, Liuyan; Shang, Huan; Liu, Lei; Chen, Weiyue; Xu, Jianfeng; Sun, Ruitao; Wang, Guangming; Zheng, Jiao; Qi, Jifang; Yang, Bo; Zeng, Lidong; Li, Yan; Lv, Hui; Zhao, Nannan; Wang, Wen; Cai, Jinsen; Liu, Yongfeng; Luo, Weiwei; Zhang, Juan; Zhang, Yanhua; Fan, Jicai; Dan, Haitao; He, Xuesen; Huang, Wei; Sun, Lei; Yan, Qin.
Afiliación
  • Chen F; GeneMind Biosciences Co., Ltd., Shenzhen 518000, China.
  • Liu B; GeneMind Biosciences Co., Ltd., Shenzhen 518000, China.
  • Chen M; GeneMind Biosciences Co., Ltd., Shenzhen 518000, China.
  • Jiang Z; GeneMind Biosciences Co., Ltd., Shenzhen 518000, China.
  • Zhou Z; GeneMind Biosciences Co., Ltd., Shenzhen 518000, China.
  • Wu P; GeneMind Biosciences Co., Ltd., Shenzhen 518000, China.
  • Zhang M; GeneMind Biosciences Co., Ltd., Shenzhen 518000, China.
  • Jin H; GeneMind Biosciences Co., Ltd., Shenzhen 518000, China.
  • Li L; GeneMind Biosciences Co., Ltd., Shenzhen 518000, China.
  • Lu L; GeneMind Biosciences Co., Ltd., Shenzhen 518000, China.
  • Shang H; GeneMind Biosciences Co., Ltd., Shenzhen 518000, China.
  • Liu L; GeneMind Biosciences Co., Ltd., Shenzhen 518000, China.
  • Chen W; GeneMind Biosciences Co., Ltd., Shenzhen 518000, China.
  • Xu J; GeneMind Biosciences Co., Ltd., Shenzhen 518000, China.
  • Sun R; GeneMind Biosciences Co., Ltd., Shenzhen 518000, China.
  • Wang G; GeneMind Biosciences Co., Ltd., Shenzhen 518000, China.
  • Zheng J; GeneMind Biosciences Co., Ltd., Shenzhen 518000, China.
  • Qi J; GeneMind Biosciences Co., Ltd., Shenzhen 518000, China.
  • Yang B; GeneMind Biosciences Co., Ltd., Shenzhen 518000, China.
  • Zeng L; GeneMind Biosciences Co., Ltd., Shenzhen 518000, China.
  • Li Y; GeneMind Biosciences Co., Ltd., Shenzhen 518000, China.
  • Lv H; GeneMind Biosciences Co., Ltd., Shenzhen 518000, China.
  • Zhao N; GeneMind Biosciences Co., Ltd., Shenzhen 518000, China.
  • Wang W; GeneMind Biosciences Co., Ltd., Shenzhen 518000, China.
  • Cai J; GeneMind Biosciences Co., Ltd., Shenzhen 518000, China.
  • Liu Y; GeneMind Biosciences Co., Ltd., Shenzhen 518000, China.
  • Luo W; GeneMind Biosciences Co., Ltd., Shenzhen 518000, China.
  • Zhang J; GeneMind Biosciences Co., Ltd., Shenzhen 518000, China.
  • Zhang Y; GeneMind Biosciences Co., Ltd., Shenzhen 518000, China.
  • Fan J; GeneMind Biosciences Co., Ltd., Shenzhen 518000, China.
  • Dan H; GeneMind Biosciences Co., Ltd., Shenzhen 518000, China.
  • He X; GeneMind Biosciences Co., Ltd., Shenzhen 518000, China.
  • Huang W; GeneMind Biosciences Co., Ltd., Shenzhen 518000, China.
  • Sun L; GeneMind Biosciences Co., Ltd., Shenzhen 518000, China.
  • Yan Q; GeneMind Biosciences Co., Ltd., Shenzhen 518000, China.
Article en En | MEDLINE | ID: mdl-38862429
ABSTRACT
DNA sequencers have become increasingly important research and diagnostic tools over the past 20 years. In this study, we developed a single-molecule desktop sequencer, GenoCare 1600 (GenoCare), which utilizes amplification-free library preparation and two-color sequencing-by-synthesis chemistry, making it more user-friendly compared with previous single-molecule sequencing platforms for clinical use. Using the GenoCare platform, we sequenced an Escherichia coli standard sample and achieved a consensus accuracy exceeding 99.99%. We also evaluated the sequencing performance of this platform in microbial mixtures and coronavirus disease 2019 (COVID-19) samples from throat swabs. Our findings indicate that the GenoCare platform allows for microbial quantitation, sensitive identification of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, and accurate detection of virus mutations, as confirmed by Sanger sequencing, demonstrating its remarkable potential in clinical application.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article